1.Clinical Study of Different Dosage Atorvastatin in Treatment of Patients with Unstable Angina post Percutaneous Coronary Intervention
Journal of Medical Research 2006;0(04):-
Objective To investigate the effects of different dosage of atorvastation on inflammatory factors in patients with unstable angina(UAP)post PCI.Methods 116 patients with their coming order were randomly divided into two groups.The observation group of 56 cases with the dosage of 20mg/d,and the control group of 60 cases with the common dosage of 10mg/d.Blood samples were examined at the day of the operation preoperatively,24 h after PCI,4W,12W after administration.Results(1)The consistency of hs-CRP and cTnI of patients after PCI were more higher than that before PCI(P
2.Clinical application of heterogeneous acellular dermal matrix used in alveolar bone grafting
Chinese Journal of Postgraduates of Medicine 2014;37(24):53-55
Objective To observe the effect of bone repair and evaluate its esthetic outcome with heterogeneous acellular dermal matrix cover the alveolar cleft bone grafting area in the alveolar cleft operation.Methods In 67 cases,unilateral cleft palate,were treated by alveolar cleft conventional surgical method.Cancellous iliac bone grafting were control group,heterogeneous acellular dermal matrix cover the alveolar cleft bone grafting area were treatment group.Radiographs was taken at 1 st,3 rd,6 th,12 th,18 th,24 th month postoperatively to observe the bone regeneration alveolar cleft zone.Results The alveolar cleft graft area new bone formation with Ⅰ,Ⅱ,Ⅲ,Ⅳ grade after 6 months in control group was 15,11,9,6 cases and in treatment group was 13,9,3,1 case.The graft survival rate and success rate (97.8%,84.3%) of treatment group were higher than that of control group (84.5%,63.7%),the difference was statistically significant (P < 0.05).Conclusion The successful rate of operation could be warranted,by the joint application of autogenous iliac bone grafts and heterogeneous acellular dermal matrix in the alveolar cleft operation.
3.Toxic Effect of Glufosinate-Ammonium on Liver of Rats
Yanzhong LIU ; Dongxia LIU ; Shuguang GAO
Journal of Environment and Health 1992;0(05):-
Objective To study the toxic effect of glufosinate-ammonium on the liver. Methods SD rats aged 6 weeks with weight of 140-160 g were randomly divided into four groups, 20 (10 males and 10 females) in each group. The rats were treated for three months by gavaging different doses of glufosinate-ammonium (0, 100, 250, 500 mg/kg bw) for the experimental group and 2% Tween-80 solution for the control group. All the rats were weighted once a week. The activity of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) in the serum were determined at the end of the study. Liver weight was measured and liver index was calculated. Pathological examination was performed. Results Treated with high-dose of glufosinate-ammonium, a retarded growth of rats was seen, the activity of ALT, AST and ALP increased significantly in both male and female rats, the liver index increased significantly and pathological changes of the liver were also observed compared with the control. No significant changes were found in the rats treated with moderate and low dose compared with the control. Conclusion Glufosinate-ammonium may produce a toxic effect on the liver of rat when the exposed dose is more than 500 mg/kg.
4.Fingerprint analysis of Spica Prunellae by HPLC
Wei LIU ; Haijie DING ; Shuguang SUN
Chinese Traditional and Herbal Drugs 1994;0(02):-
Objective To establish a method of fingerprint analysis on Spica Prunellae by HPLC.Methods The HPLC method was used,chromatographic conditions were Betasil C18 column(250 mm ? 4.6 mm,5 ?m),acetonitrile-0.1% phosphric acid system as mobile phase,0-50 min acetonitrile 10%→25%,50-60 min acetonitrile 25%→32%;flow rate 0.7 mL/min;detective wavelength at 210 nm,column temperature 25 ℃.Results Establishing the fingerprint of Spica Prunellae,16 common peaks were found in the HPLC fingerprint of Spica Prunellae and good similarities with correlation coefficients over 0.95 were found in the fingerprints between the herbs from different sources and standard fingerprint,which could be utilized for the identification of Spica Prunellae.Conclusion The method is accuate,simple,and could be used for the quality control of Spica Prunellae.
5.Study of mitochondrial DNA point mutations at positions 3243, 8993 in hereditary ataxia
Jing WANG ; Huihua LIU ; Shuguang LUO
Journal of Clinical Neurology 1988;0(02):-
Objective To study the possible relationship between mitochondrial DNA point mutations and hereditary ataxia (HA). Methods Polymerase chain reaction (PCR), restriction fragment length polymophism (RFLP) were performed to search A3243G, T8993G or T8993C point mutations in the amplified mitochondrial DNA of extract human perpheral white blood cells of 26 patients with HA and 35 normal controls. Results No point mutations of mitochondrial DNA A3243G, T8993G or T8993C were found in HA group and control group.Conclusion mitochondrial DNA A3243G, T8993G and T8993C mutations are not likely to be genetic factors of hereditary ataxia.
6.p53 mutation and microsatellite alteration in T cell lymphoma:38 cases
Chunying LUO ; Fei DENG ; Shuguang LIU
Journal of Third Military Medical University 1988;0(05):-
0.05). Conclusion There are MA and mutation of p53 gene in T-cell lymphoma though no significant correlation between them. But, MA positive cases might experience high mutation of p53 gene in T-cell lymphoma.
7.All-round administrating scientific research grants to ensure their quality
Shuguang ZHANG ; Yuxiu LIU ; Jun ZHENG
Journal of Medical Postgraduates 2003;0(03):-
Grant administration in hospitals is one of the important tasks for administrators of scientific research, and all leaders should also pay enough attention to it and regard it as a strategic assignment of hospital development. In this paper, we found out the key points in different phases of scientific researches through quality analysis of grants and the whole procedure of research, and put forward the keystone administration. We also discussed a new model of subject construction, thesis and achievements administration leaded by grant administration, which should basically and greatly raise the level of scientific research in the hospital.
8.Peptidic HIV fusion inhibitors targeting envelope glycoprotein transmembrane subunit gp41
Shuwen LIU ; Shuguang WU ; Shib JIANG
Chinese Pharmacological Bulletin 2003;0(11):-
HIV envelope glycoprotein transmembrane subunit gp41 plays a major role in the fusion of viral and target cell membranes. The extracellular region of gp41 consists of N-terminal fusion peptide and downstream N- and C-heptad repeat (NHR and CHR) regions. The peptidesderived from the NHR and CHR regions, designated N- and C-peptides, respectively, have potent inhibitory activity on the HIV mediated cell fusion. C-peptide T-20 has just got the approval of U.S. FDA, which became the first success of one new class anti-HIV agents, named HIV-fusion inhibitors. However, a relatively long peptide such as T-20 suffers from several limitations including proteolytic sensitivity, large dosage, therefore it is unable to produced by gene engineering. Alternately, shorter peptidic fusion inhibitors and active peptides suitable for gene engineering are pursued. In the recent years, this kind of peptide modifications are hot spots in HIV research field and contribute a lot to the inhibitory mechanism of N- and C-peptide.
9.5-HT RECEPTOR BLOCKADE PROPERTIES OF STEPHANINE AND OTHER TETRAHYDROQUINOLINE ALKALOIDS
Guoqing LIU ; Shuguang CHEN ; Zhiqin MA
Chinese Pharmacological Bulletin 1987;0(02):-
Studies using isolated rat fundus strip preparation demonstrated that l-stephanine ( l-STP ) , l-roemerine ( 1-REM ), l-stepholidine (l-SPD), 1-tetrahydropalmatine ( l-THP ) and dl-tetrahydrode-berine ( THB ) possessed 5-HT blockade properties. 1-STP ( 16, 25 ?M ) produced competitve antagonism against 5-HT receptor on rat fundus, while higher concentration ( 50 ?M ) suggested a non-competi tive inhibition, with pA2' and2' values equal to 5.8 and 4.2 respectively. 1-REM was found to be a non-competitive antagonIst ( pD' 2 = 4.5). 1-SPD, 1-THP and THB cuased a parallel shift to the right of 5-HT concentration response curve without any significant changes in their maximum response, indicating that they were competitive antagonists of 5-HT receptor. The antagonistic potencies of 1-SPD, l-THP and THB were expressed as pA2 values: 6.2,5.2 and 5.0.
10.Loss of multi-sites allde heterozygosity on chromosome 9 in esophageal carcinoma
Jianmeng GUO ; Shuguang YAN ; Fucai LIU
Cancer Research and Clinic 2008;20(10):690-694
Objective To investigate the gene variation and the dependability and to evaluate the possible tumor suppressor genes on chromosome 9 in the development and progression of EC. Methods LOH was detected in normal esophageal mucosa, high-grade squamous dysplasia and esophageal squamous cell carcinoma by microdissection, polymerase chain reaction, denaturing polyacrylamide gel eleetrophoresis and silver nitrate staining technology. The changes of LOH at six microsatellite markers and the relationship between LOH rate were analyzed. Results In the informative cases, total frequency of LOH was 17.2 % in high-grade squamous dysplasia and 24.9 % in esophageal squamous cell carcinoma. In high grade squamous dysplasia and squamous cell carcinoma, LOH was detected at marker D9S162 (20.8 %, 36.7 %), D9S171 (33.3 %, 36 %), D9S753(34.8 %, 46.2 %), D9S1748(4.2 %, 13.8 %), D9S242(14.3 %, 21.2 %), D9S43(0, 0). The frequency of LOH showed significant difference among the six microsatellite markers (X2=17.26, P< 0.005; X2=22.66,P<0.005). Conclusion The progression from normal squamous epithelium to high-grade Squamous dysplasia and subsequently to squamous cell carcinoma of the esophagus is associated with accumulation of chromosomal change. The situs of D9S171, D9S162, D9S242, D9S753 exist higher LOH and all exceed 20 %. Possible tumor suppressor genes at or near D9S171, D9S162, D9S242, D9S753 may be related to the progression of esophageal squamous cell carcinoma.